467 related articles for article (PubMed ID: 12438853)
41. Amplification in the rehabilitation of unilateral deafness: speech in noise and directional hearing effects with bone-anchored hearing and contralateral routing of signal amplification.
Lin LM; Bowditch S; Anderson MJ; May B; Cox KM; Niparko JK
Otol Neurotol; 2006 Feb; 27(2):172-82. PubMed ID: 16436986
[TBL] [Abstract][Full Text] [Related]
42. The efficacy of unilateral bone-anchored hearing devices in Chinese Mandarin-speaking patients with bilateral aural atresia.
Fan Y; Zhang Y; Wang P; Wang Z; Zhu X; Yang H; Chen X
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):357-62. PubMed ID: 24503772
[TBL] [Abstract][Full Text] [Related]
43. Profound high-frequency sensorineural hearing loss treatment with a totally implantable hearing system.
Shohet JA; Kraus EM; Catalano PJ
Otol Neurotol; 2011 Dec; 32(9):1428-31. PubMed ID: 22072264
[TBL] [Abstract][Full Text] [Related]
44. Assessment of Hearing Aid Benefit Using Patient-Reported Outcomes and Audiologic Measures.
Dornhoffer JR; Meyer TA; Dubno JR; McRackan TR
Audiol Neurootol; 2020; 25(4):215-223. PubMed ID: 32241007
[TBL] [Abstract][Full Text] [Related]
45. Comparison of speech discrimination in noise and directional hearing with 2 different sound processors of a bone-anchored hearing system in adults with unilateral severe or profound sensorineural hearing loss.
Wesarg T; Aschendorff A; Laszig R; Beck R; Schild C; Hassepass F; Kroeger S; Hocke T; Arndt S
Otol Neurotol; 2013 Aug; 34(6):1064-70. PubMed ID: 23856626
[TBL] [Abstract][Full Text] [Related]
46. A comparison of threshold-based fitting strategies for nonlinear hearing aids.
Stelmachowicz PG; Dalzell S; Peterson D; Kopun J; Lewis DL; Hoover BE
Ear Hear; 1998 Apr; 19(2):131-8. PubMed ID: 9562535
[TBL] [Abstract][Full Text] [Related]
47. Phase III clinical trial results with the Vibrant Soundbridge implantable middle ear hearing device: a prospective controlled multicenter study.
Luetje CM; Brackman D; Balkany TJ; Maw J; Baker RS; Kelsall D; Backous D; Miyamoto R; Parisier S; Arts A
Otolaryngol Head Neck Surg; 2002 Feb; 126(2):97-107. PubMed ID: 11870337
[TBL] [Abstract][Full Text] [Related]
48. Phase 1 clinical trial results of the Envoy System: a totally implantable middle ear device for sensorineural hearing loss.
Chen DA; Backous DD; Arriaga MA; Garvin R; Kobylek D; Littman T; Walgren S; Lura D
Otolaryngol Head Neck Surg; 2004 Dec; 131(6):904-16. PubMed ID: 15577788
[TBL] [Abstract][Full Text] [Related]
49. Otologics fully implantable hearing system: Phase I trial 1-year results.
Jenkins HA; Atkins JS; Horlbeck D; Hoffer ME; Balough B; Alexiades G; Garvis W
Otol Neurotol; 2008 Jun; 29(4):534-41. PubMed ID: 18317397
[TBL] [Abstract][Full Text] [Related]
50. U.S. Phase I preliminary results of use of the Otologics MET Fully-Implantable Ossicular Stimulator.
Jenkins HA; Atkins JS; Horlbeck D; Hoffer ME; Balough B; Arigo JV; Alexiades G; Garvis W
Otolaryngol Head Neck Surg; 2007 Aug; 137(2):206-12. PubMed ID: 17666242
[TBL] [Abstract][Full Text] [Related]
51. Improvement of speech perception in quiet and in noise without decreasing localization abilities with the bone conduction device Bonebridge.
Weiss R; Leinung M; Baumann U; Weißgerber T; Rader T; Stöver T
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2107-2115. PubMed ID: 28032241
[TBL] [Abstract][Full Text] [Related]
52. Audiological and subjective benefit results in bone-anchored hearing device users.
Boleas-Aguirre MS; Bulnes Plano MD; de Erenchun Lasa IR; Ibáñez Beroiz B
Otol Neurotol; 2012 Jun; 33(4):494-503. PubMed ID: 22472615
[TBL] [Abstract][Full Text] [Related]
53. Effects of sensorineural hearing loss and personal hearing AIDS on cortical event-related potential and behavioral measures of speech-sound processing.
Korczak PA; Kurtzberg D; Stapells DR
Ear Hear; 2005 Apr; 26(2):165-85. PubMed ID: 15809543
[TBL] [Abstract][Full Text] [Related]
54. A middle ear implant, the Symphonix Vibrant Soundbridge: retrospective study of the first 125 patients implanted in France.
Sterkers O; Boucarra D; Labassi S; Bebear JP; Dubreuil C; Frachet B; Fraysse B; Lavieille JP; Magnan J; Martin C; Truy E; Uziel A; Vaneecloo FM
Otol Neurotol; 2003 May; 24(3):427-36. PubMed ID: 12806295
[TBL] [Abstract][Full Text] [Related]
55. Impact of visual cues on directional benefit and preference: Part I--laboratory tests.
Wu YH; Bentler RA
Ear Hear; 2010 Feb; 31(1):22-34. PubMed ID: 19864954
[TBL] [Abstract][Full Text] [Related]
56. Speech recognition performance of patients with sensorineural hearing loss under unaided and aided conditions using linear and compression hearing AIDS.
Shanks JE; Wilson RH; Larson V; Williams D
Ear Hear; 2002 Aug; 23(4):280-90. PubMed ID: 12195170
[TBL] [Abstract][Full Text] [Related]
57. Totally implantable active middle ear implant: Hearing and safety results in a large series.
Shohet JA; Gende DM; Tanita CS
Laryngoscope; 2018 Dec; 128(12):2872-2878. PubMed ID: 30194720
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of a new powerful bone-anchored hearing system: a comparison study.
Bosman AJ; Snik AF; Hol MK; Mylanus EA
J Am Acad Audiol; 2013 Jun; 24(6):505-13. PubMed ID: 23886427
[TBL] [Abstract][Full Text] [Related]
59. Comparison of different vibrant soundbridge audioprocessors with conventional hearing AIDS.
Todt I; Seidl RO; Gross M; Ernst A
Otol Neurotol; 2002 Sep; 23(5):669-73. PubMed ID: 12218618
[TBL] [Abstract][Full Text] [Related]
60. Effect of a Bluetooth-implemented hearing aid on speech recognition performance: subjective and objective measurement.
Kim MB; Chung WH; Choi J; Hong SH; Cho YS; Park G; Lee S
Ann Otol Rhinol Laryngol; 2014 Jun; 123(6):395-401. PubMed ID: 24687593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
